Company registration number 13216343 (England and Wales)
HEALTH MEDICA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
PAGES FOR FILING WITH REGISTRAR
HEALTH MEDICA LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
HEALTH MEDICA LIMITED
BALANCE SHEET
AS AT
28 FEBRUARY 2026
28 February 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Intangible assets
3
73,057
98,879
Tangible assets
4
4,991
7,647
78,048
106,526
Current assets
Stocks
502,070
607,929
Debtors
5
165,760
179,456
Investments
6
525,437
-
0
Cash at bank and in hand
1,601,394
1,438,747
2,794,661
2,226,132
Creditors: amounts falling due within one year
7
(698,486)
(674,583)
Net current assets
2,096,175
1,551,549
Net assets
2,174,223
1,658,075
Capital and reserves
Called up share capital
8
296
296
Profit and loss reserves
2,173,927
1,657,779
Total equity
2,174,223
1,658,075

For the financial year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 22 June 2026 and are signed on its behalf by:
T Sullivan
Director
Company registration number 13216343 (England and Wales)
HEALTH MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 2 -
1
Accounting policies
Company information

Health Medica Limited is a private company limited by shares incorporated in England and Wales. The registered office is 10 Cassiobury Park Avenue, Watford, Herts, WD18 7LB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website development
Over 48-60 months
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Office equipment
25% straight line
Computers
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

HEALTH MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
1
Accounting policies
(Continued)
- 3 -
1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Basic financial liabilities

Basic financial liabilities are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

HEALTH MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
1
Accounting policies
(Continued)
- 4 -
1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
7
6
3
Intangible fixed assets
Website development
£
Cost
At 1 March 2025 and 28 February 2026
142,668
Amortisation and impairment
At 1 March 2025
43,789
Amortisation charged for the year
25,822
At 28 February 2026
69,611
Carrying amount
At 28 February 2026
73,057
At 28 February 2025
98,879
HEALTH MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 5 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 March 2025
11,847
Additions
1,224
Disposals
(2,717)
At 28 February 2026
10,354
Depreciation and impairment
At 1 March 2025
4,200
Depreciation charged in the year
3,063
Eliminated in respect of disposals
(1,900)
At 28 February 2026
5,363
Carrying amount
At 28 February 2026
4,991
At 28 February 2025
7,647
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
89,137
83,023
Other debtors
76,623
96,433
165,760
179,456
6
Current asset investments
2026
2025
£
£
Other investments
525,437
-
0
7
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
151,837
58,575
Taxation and social security
330,217
302,830
Other creditors
216,432
313,178
698,486
674,583
HEALTH MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 6 -
8
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of £1 each
50
50
50
50
Ordinary B shares of £1 each
50
50
50
50
Ordinary C shares of £1 each
49
49
49
49
Ordinary D shares of £1 each
49
49
49
49
Ordinary E shares of £1 each
49
49
49
49
Ordinary F shares of £1 each
49
49
49
49
296
296
296
296
9
Operating lease commitments
As lessee

The lease is for office rental.

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2026
2025
£
£
Total commitments
125,916
173,135
2026-02-28 2025-03-01 false false false 10 August 2026 CCH Software CCH Accounts Production 2026.200 No description of principal activity T Sullivan C Sullivan 13216343 2025-03-01 2026-02-28 13216343 2026-02-28 13216343 2025-02-28 13216343 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2026-02-28 13216343 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-02-28 13216343 core:WithinOneYear 2026-02-28 13216343 core:WithinOneYear 2025-02-28 13216343 core:CurrentFinancialInstruments core:WithinOneYear 2026-02-28 13216343 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 13216343 core:ShareCapital 2026-02-28 13216343 core:ShareCapital 2025-02-28 13216343 core:RetainedEarningsAccumulatedLosses 2026-02-28 13216343 core:RetainedEarningsAccumulatedLosses 2025-02-28 13216343 core:ShareCapitalOrdinaryShareClass1 2026-02-28 13216343 core:ShareCapitalOrdinaryShareClass1 2025-02-28 13216343 core:ShareCapitalOrdinaryShareClass2 2026-02-28 13216343 core:ShareCapitalOrdinaryShareClass2 2025-02-28 13216343 core:ShareCapitalOrdinaryShareClass3 2026-02-28 13216343 core:ShareCapitalOrdinaryShareClass3 2025-02-28 13216343 core:ShareCapitalOrdinaryShareClass4 2026-02-28 13216343 core:ShareCapitalOrdinaryShareClass4 2025-02-28 13216343 core:ShareCapitalOrdinaryShareClass5 2026-02-28 13216343 core:ShareCapitalOrdinaryShareClass5 2025-02-28 13216343 core:ShareCapitalOrdinaryShares 2026-02-28 13216343 core:ShareCapitalOrdinaryShares 2025-02-28 13216343 bus:Director1 2025-03-01 2026-02-28 13216343 core:IntangibleAssetsOtherThanGoodwill 2025-03-01 2026-02-28 13216343 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-03-01 2026-02-28 13216343 core:FurnitureFittings 2025-03-01 2026-02-28 13216343 core:ComputerEquipment 2025-03-01 2026-02-28 13216343 2024-03-01 2025-02-28 13216343 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-02-28 13216343 core:OtherPropertyPlantEquipment 2025-02-28 13216343 core:OtherPropertyPlantEquipment 2026-02-28 13216343 core:OtherPropertyPlantEquipment 2025-03-01 2026-02-28 13216343 core:OtherPropertyPlantEquipment 2025-02-28 13216343 core:CurrentFinancialInstruments 2026-02-28 13216343 core:CurrentFinancialInstruments 2025-02-28 13216343 bus:OrdinaryShareClass1 2025-03-01 2026-02-28 13216343 bus:OrdinaryShareClass2 2025-03-01 2026-02-28 13216343 bus:OrdinaryShareClass3 2025-03-01 2026-02-28 13216343 bus:OrdinaryShareClass4 2025-03-01 2026-02-28 13216343 bus:OrdinaryShareClass5 2025-03-01 2026-02-28 13216343 bus:OrdinaryShareClass1 2026-02-28 13216343 bus:OrdinaryShareClass1 2025-02-28 13216343 bus:OrdinaryShareClass2 2026-02-28 13216343 bus:OrdinaryShareClass2 2025-02-28 13216343 bus:OrdinaryShareClass3 2026-02-28 13216343 bus:OrdinaryShareClass3 2025-02-28 13216343 bus:OrdinaryShareClass4 2026-02-28 13216343 bus:OrdinaryShareClass4 2025-02-28 13216343 bus:OrdinaryShareClass5 2026-02-28 13216343 bus:OrdinaryShareClass5 2025-02-28 13216343 bus:AllOrdinaryShares 2026-02-28 13216343 bus:AllOrdinaryShares 2025-02-28 13216343 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 13216343 bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 13216343 bus:FRS102 2025-03-01 2026-02-28 13216343 bus:AuditExemptWithAccountantsReport 2025-03-01 2026-02-28 13216343 bus:Director2 2025-03-01 2026-02-28 13216343 bus:FullAccounts 2025-03-01 2026-02-28 xbrli:pure xbrli:shares iso4217:GBP